Filing News

PITTSBURGH--(BUSINESS WIRE)--Smith Micro Software, Inc. (Nasdaq: SMSI) announced the filing with the Securities and Exchange Commission (“SEC”) of (i) a registration statement on Form S-1 solely to register for resale shares of common stock underlying securities previously issued in the Company’s financing transaction completed and disclosed in June 2026 and (ii) a registration statement on Form S-8 to register additional shares for issuance under the Company’s Amended and Restated Omnibus Equi...

MIAMI--(BUSINESS WIRE)--The Real Brokerage Inc. Announces Filing and Mailing of Meeting Materials for the Special Meeting of Securityholders to be held on August 14, 2026....

JERSEY CITY, N.J.--(BUSINESS WIRE)--Copper Property CTL Pass Through Trust (“the Trust”) has filed a Form 8-K containing the Q1-2026 consolidated financial statements of Penney Intermediate Holdings LLC for the period ended May 2, 2026 and May 3, 2025, respectively and the Q1-2026 Master Lease JCP store performance disclosures Additional information, including the Trust’s Monthly and Quarterly Reports, as well as other filings with the Securities and Exchange Commission (“SEC”) can be accessed...

BOZEMAN, Mont.--(BUSINESS WIRE)--PSQ Holdings, Inc. (NYSE: PSQH) (the “Company” or “PSQ Holdings”) today announced that a 1-for-15 reverse stock split of the Company’s Class A common stock will become effective on July 13, 2026. The Company's Class A common stock will begin trading on a split-adjusted basis at the opening of the market on July 13, 2026, under the existing ticker symbol “PSQH” and a new CUSIP number, 693691 206. “Over the past year, we rebuilt this company into a focused, growin...

JERSEY CITY, N.J.--(BUSINESS WIRE)--Copper Property CTL Pass Through Trust (“the Trust”) has filed a Form 14-C announcing that the Trust Agreement has been amended to extend the Trust Termination Date by 60 days to August 28, 2026, by written consent of the majority of the Certificateholders. Additional information, including the Trust’s Monthly and Quarterly Reports, as well as other filings with the Securities and Exchange Commission (“SEC”) can be accessed via the Trust’s website at www.ctlt...

MIAMI BEACH, Fla.--(BUSINESS WIRE)--LQR House Inc. (the “Company” or “LQR House”) (NASDAQ:YHC), a niche ecommerce platform specializing in the spirits and beverage industry, today announced that the Company’s Board of Directors (the “Board”) approved a reverse stock split (the “Reverse Stock Split”) of LQR House’s shares of Common Stock, par value $0.0001 per share (the “Common Stock”), at a ratio of 1-for-100 (the “Reverse Stock Split Ratio”). The Company filed its Certificate of Amendment to...

MIAMI--(BUSINESS WIRE)--duPont REGISTRY Group Announces Confidential Filing of Draft Registration Statement for Proposed Initial Public Offering...

NEW YORK--(BUSINESS WIRE)--Cantor Equity Partners I, Inc. (Nasdaq: CEPO) ("CEPO"), a special purpose acquisition company sponsored by an affiliate of Cantor Fitzgerald, today announced that CEPO and BSTR Holdings, Inc. ("BSTR") have agreed to work together on and are currently discussing a potential revised structure and amended terms for their previously announced proposed business combination. Such revised structure and amended terms for the proposed business combination are intended to bette...

TOKYO--(BUSINESS WIRE)--Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2026 (the “Annual Report”) with the U.S. Securities and Exchange Commission on July 6, 2026. The Annual Report includes MUFG’s audited consolidated financial statements prepared under U.S. GAAP as of and for the fiscal year ended March 31, 2026.The Annual Report is available on our websi...

BOSTON & SAN DIEGO--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, today announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of approximately $10.0 billion, or approximately...